ID: h-gap-456a357b-m3
Hypothesis
protective chromatin remodeling defines the therapeutic window for: Are DNA methylation changes in neurodegeneration causal drivers or protective cons
The same signal may be beneficial early and damaging late.
EvidencePending (0%)📖 6 cit🗣 1 debates✓ 6 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell methylome tracking should reveal a disease-stage interaction and define when intervention is protective versus counterproductive.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Protective Chromatin Remodeling<br/>Early Stress-Adaptive State"]
B["H3K27ac Gain at Defense Loci<br/>NRF2 and FOXO3 Target Activation"]
C["H3K9me3 Deployment<br/>Transposon and Repeat Silencing"]
D["Stage-Dependent Transition<br/>Adaptive to Pathological Shift"]
E["Late-Stage Heterochromatin Loss<br/>Progressive Chromatin Collapse"]
F["Early Intervention Window<br/>Chromatin Reinforcement Strategy"]
G["Epigenome Targeting Therapy<br/>HDAC Inhibitor or DNMT Modulator"]
A --> B
A --> C
B --> D
C --> D
D --> E
F -.->|"extends"| A
G -.->|"implements"| F
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix5 supports1 contradicts
Supports
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Supports
Human endogenous retrovirus-K contributes to motor neuron disease.
Supports
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Supports
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (10)Export BibTeX ↗
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell (2020) · PubMed:33031745 ↗
12 figures

Figure 1
No caption available

Figure S1
Elevated NF-κB and Type I IFN Signaling Because of TDP-43 In Vitro , Related to Figure 1 (A) Doxycycline (Dox inducible wild-type (WT) or ALS mutant (Q331K) T...
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell (2020) · PubMed:33031745 ↗
No figures
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.
Autophagy (2020) · PubMed:31204559 ↗
No figures
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.
Autophagy (2020) · PubMed:31204559 ↗
No figures
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Nature neuroscience (2019) · PubMed:30643298 ↗
No figures
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Nature neuroscience (2019) · PubMed:30643298 ↗
No figures
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural plasticity (2018) · PubMed:27313899 ↗
No figures
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural Plast (2016) · PubMed:27313899 ↗
No figures
Human endogenous retrovirus-K contributes to motor neuron disease.
Science translational medicine (2015) · PubMed:26424568 ↗
No figures
Human endogenous retrovirus-K contributes to motor neuron disease.
Science translational medicine (2015) · PubMed:26424568 ↗
No figures
🏥 Translation
🧬 3D Protein Structure — PROTECTIVE
No curated PDB or AlphaFold mapping for PROTECTIVE yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for protective chromatin remodeling.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.2317
Events (7d)
0
Price History
▼27.1%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF the remodeling is protective rather than pathological, THEN individuals with higher baseline protective chromatin signatures will show >=15% slower NfL increase over 2 years despite comparable base | Top-quartile protective signature predicts >=15% lower annual plasma NfL slope than bottom quartile. | — no observation — | pending | 0.49 |
| IF protective chromatin remodeling defines the therapeutic window, THEN enhancing the remodeling program before stress will improve neuronal survival by >=20%, whereas the same enhancement after injur | Pre-stress enhancement yields >=20% survival benefit and post-injury enhancement yields <5% benefit. | — no observation — | pending | 0.54 |
🔮 Falsifiable Predictions (2)
pendingconf 54%
IF protective chromatin remodeling defines the therapeutic window, THEN enhancing the remodeling program before stress will improve neuronal survival by >=20%, whereas the same enhancement after injury onset will improve survival by <5%.
Predicted outcome: Pre-stress enhancement yields >=20% survival benefit and post-injury enhancement yields <5% benefit.
Falsification: Timing does not modify response or late enhancement is equally protective.
pendingconf 49%
IF the remodeling is protective rather than pathological, THEN individuals with higher baseline protective chromatin signatures will show >=15% slower NfL increase over 2 years despite comparable baseline pathology.
Predicted outcome: Top-quartile protective signature predicts >=15% lower annual plasma NfL slope than bottom quartile.
Falsification: NfL slopes differ by <5% or top-quartile participants decline faster.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.